And speaking of ROS (reactive oxygen Species) vs antioxidants( warning, you never know where there might be bias, and watch for small studies etc, still, food for thought)
A 12 Week,
open Label, Phase I/IIa Study Using ApatoneĀ® for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy:
www.ncbi.nlm.nih.gov/pmc/articles/PMC2288789/Serum Markers Variation Consistent with Autoschizis Induced
by Ascorbic AcidāMenadione in Patients with Prostate Cancer
www.euro-med.us/dr-lasalvia-publications.pdf (scroll down to PDF page 24 of 97 or type in 24 into the PDF page # or go to page 45 in one of the articles by Lasalvia) or abstract:
www.ncbi.nlm.nih.gov/pubmed/12665684Vitamin K3 and vitamin C alone or in combination induced apoptosis in leukemia cells by a similar
oxidative stress signalling mechanism.
www.ncbi.nlm.nih.gov/pubmed/21663679Apoptosis-inducing activity of vitamin C and vitamin K. "Vitamin C shows both reducing and oxidizing activities, depending on the environment in which this vitamin is present. Higher concentrations of vitamin C induce apoptotic cell death in various tumor cell lines including oral squamous cell carcinoma and salivary gland tumor cell lines, possibly via its
prooxidant action."
www.ncbi.nlm.nih.gov/pubmed/10726979The vitamin C:vitamin K3 system - enhancers and inhibitors of the anticancer effect. ( studying which anti-oxidants, such as melatonin, inhibit a VitC/VitK3's PC killing abilities via ROS)
www.ncbi.nlm.nih.gov/pubmed/21194250Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice.
www.ncbi.nlm.nih.gov/pubmed/16828058Inhibition of the development of metastases by dietary vitamin C:K3 combination:
www.ncbi.nlm.nih.gov/pubmed/15193956